Orphan Drugs: Hope Where There Is Little or No Hope
NEW YORK, N.Y., February 18, 2004 ? On a visit to his doctor, Gary Jacob received distressing news ? not about himself, but a friend of the doctor's. While playing with one of his children, the doctor's friend fell and broke a rib. That was bad enough, but during the examination at the hospital, the father was hit with a startling and totally unexpected diagnosis ? he had a disease known as multiple myeloma, a bone marrow blood cancer. The diagnosis was nothing less than a death sentence. Jacob knew of the anguish of multiple myeloma patients. The disease is incurable and nearly always fatal, one of the rare diseases that have few, if any, available treatments. They are known as "orphan" diseases, shunned by most drug-makers because the patient populations are small and commercial development of a drug is seen as economically unattractive. Mr. Jacob was aware because, as Chief Executive Officer of Callisto Pharmaceuticals, Inc., a small Manhattan-based biopharmaceutical company, he is leading a scientific effort to develop a new orphan drug called "Atiprimod" for multiple myeloma patients. "The father's disease brought home to me that what we are doing is really important," says Mr. Jacob. "Everyone agrees we need more drugs to treat multiple myeloma. There are people out there dying without real hope because of a lack of effective treatment for all patients." In steadily increasing numbers, orphan drugs are providing new doses of hope where little or none at all existed. In the decade before the inception of the federal Food and Drug Administration's orphan drug program, 10 drugs were developed by pharmaceutical companies for orphan diseases. In the decades since, the FDA says nearly 250 new drugs were developed and approved, and hundreds more are in the pipeline. Atiprimod is one of those wending its way toward the marketplace. Callisto recently obtained orphan drug designation from the FDA, providing the company with financial incentives to continue the costly development process. The program covers drugs for orphan diseases with patient populations under 200,000. The National Organization for Rare Disorders reports about 25 million people in the United States suffer from an estimated 6,000 orphan diseases. Diseases such as cystic fibrosis, complications affecting HIV-infected people, Gaucher's disease, hemophilia and rare forms of cancer were among the orphans without effective medicines until the FDA program went into effect in 1983 and paved the way for new drugs for patients with these diseases. Large drug-makers have been largely missing from the efforts. According to the orphan drug program's deputy director, Dr. John McCormick, only 15% of applications for orphan drug designation have come from the larger pharmaceutical companies. The reason: expectations of unfavorable investment returns. The FDA orphan drug incentives ? grants, seven years of marketing exclusivity and tax breaks ? have drawn small pharmaceutical companies with promising drug candidates into the breach. While the future is brighter, the task is still daunting to develop drugs for orphan diseases. Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, affects 30,000 Americans with 8,000 new cases diagnosed annually; Huntington's disease also affects about 30,000 patients. Some diseases affect fewer than 100 patients, according to the National Institutes of Health. An estimated 50,000 patients have multiple myeloma with 15,000 new patients diagnosed each year. Last year, the FDA approved a new drug Velcade for patients with the disease. However, there are still a number of multiple myeloma patients with no treatment available. Dr. Kenneth C. Anderson, who played a major role in the preclinical development and clinical trials of Velcade and is now a member of Callisto's Medical Advisory Board, is among the experts who see a need for more drugs to treat multiple myeloma. "He is excited to see Atiprimod enter clinical trials for evaluation in multiple myeloma patients," Jacob said of Anderson. "He believes it has an opportunity to help patients who have not responded to other drugs. " Dr. Anderson is director of the Jerome Lipper Multiple Myeloma Center of the Dana-Farber Cancer Institute in Boston, MA, and Professor of Medicine at Harvard Medical School. The Phase I/IIa trials for Atiprimod are slated to begin later this month. Dr. Donald Picker, Callisto's Senior Vice President of Drug Development, said studies of Atiprimod in collaboration with scientists at the National Cancer Institute have been very promising. "In essence, we've shown in these early studies that Atiprimod has the potential to intervene with cancer cells and tumors in three ways ? by inhibiting their formation, by programming their death and by limiting their ability to grow blood vessels necessary for their survival. Taken together, these findings suggest that Atiprimod could potentially represent a novel class of compounds for development for therapeutic intervention in human cancers," said Dr. Picker. About The Author Alex Michelini is a former award-winning reporter/editor at the New York Daily News. His credits include nomination for a Pulitzer Prize for a series on medical costs. Among his honors, Mr. Michelini received the Deadline Club Award, the Page One Award, the Associated Press Award and the New York Press Club Award (twice). He is the founder of Alex Michelini Public Relations, and has developed and collaborated on articles appearing in the New York Times, the Wall Street Journal, the London Times, the New York Post, the New York Daily News, Bloomberg Radio & TV, CNNfn, WCBS Radio & TV. WINS radio, the Christian Science Monitor, Fox TV, Reuters, Newsday and other media outlets. michelinialex@aol.com
Related News
|
 |
|
|
RELATED ARTICLES
Three Antioxidants (ginko biloba, grade seed extract, and selenium) for Alzheimers Treatment
Checklist of Treatments for Alzheimer's Disease
Cold-Eeze Side Effects Lawyer: Zinc Destroys Sense of Smell!
Cold-Eeze is a homeopathic solution to the common cold. It is a zinc-based solution that can be taken as a tablet or a nasal spray. Limited studies have found that the nasal spray reduces the duration of the common cold to less than three days, down from an average nine days. These amazing results have lead thousands of Americans to try this new medication, with terrible results.
Benefits of a Virtual Top Doctor Consultant
Looking for the best doctor to suite your medical needs can be a problem, especially if you don't have time and you need to research the doctor's credentials. Whether you're in urgent need of help, or just need a second opinion, I will show you how to access all the information you need ? through the Internet's Virtual Top Doctor Consultant.
How Do I Choose The Best Arthritis Medicine?
Are you spending a fortune on prescription arthritis medicines? Are they helping? Are you concerned about side effects? You may think a particular drug is a miraculous godsend. Yet, someone you know may take the same dose only to experience little relief and life-threatening side effects. All of the choices can be confusing.
10 Home Remedies For Arthritis Pain Relief
Your Remedy No. 1
==============
The Lower Cost Prescription Drug Alternative
Today in the United States, there are hundreds of thousands of people who do not have and cannot afford adequate health care coverage. Sadly, many must pay out of pocket for medical treatment of any kind, not to mention much needed prescriptions. These expenses can add up quickly and are usually very costly. Consumers often find themselves cutting back on other expenses, in order to pay for medical procedures and medication. Oftentimes they are forced to go without.
Watch Out for Misleading Pharmaceutical Advertising
In 1997, the Food and Drug Administration relaxed the rules for drug advertising on television and radio. Since that time, the airwaves have been flooded with commercials for all sorts of drugs. Some of them are vague, with a simple "Ask your doctor if drug x is right for you"; others spell out what the drug is used for and devote the commercial to telling you how much you will appreciate your product. Most consumers will probably assume that these commercials are honest, that the drugs will do what the ads say they will do, and that there are no side effects other than those mentioned in the ad. That may not be true, and consumers should be aware that the ads may not tell the whole story, and that they may be misleading.The pharmaceutical industry spends $9 billion per year advertising their products, and the money they spend on television and radio ads is probably the most effective. Doctors may be skeptical of a product touted by a salesman, but consumers are easily swayed by television ads that show people living happy, productive lives while being treated for an ailment using the advertised product. Unfortunately, these ads may not be completely honest. In 2004, the FDA investigated thirty-six ads for drugs that the agency found to be misleading or incomplete in their descriptions of side effects. Consumers might think that the commercials must be honest, since the FDA wouldn't allow dishonest commercials to air. Unfortunately, that's not the case. The FDA does not require pharmaceutical companies to provide screening copies of their advertisements prior to airing. The FDA doesn't actually see the ads until the consumers do. Several months may pass before the FDA takes action. In the case of misleading advertising, the most the FDA can usually do is ask the companies to either stop running the ads or to change them. These requests aren't always timely, however. In the last five years, the FDA has asked the drug companies to stop running several ads that had already stopped running!What this means for consumers is that some doubt should be exercised while viewing a commercial for a new drug. If you think an advertised product may be useful to you, discuss it with your physician, but ask if they know of any problems associated with the product. Research the product on the Internet. When your health is at stake, a little caution may be a good idea.
10 Reasons To Buy Drugs From An Online Canadian Pharmacy
1. Online Canadian pharmacies offer overall best prices on Canadian drugs, as well as on international drugs. This is due to the fact that there are many online Canadian pharmacies and they lower their prices to increase the sales number.
Protect Yourself Against the Flu Vaccine!
The vaccine industry insists that their vaccines against the flu serve as the key to a healthy winter. Although there has not been a serious flu epidemic for 38 years, their vaccines are prescribed to millions of people each year. You may wonder why perfectly healthy people are injected with a normally harmless bug whose strains mutate from year to year? Although flu vaccines can never be accurate, encouraged by their employers, millions of employees submit to a flu jab each year, trying to avoid the loss of working days.
Naproxen Lawyer: Aleve Recall Consideration
Naproxen belongs to a class of drugs called non-steroidal anti-inflammatory drugs. This basically means it's a common pain reliever among the ranks of ibuprofen (Motrin), indomethacin (Indocin), nabumentone (Relafen), and several others you are probably familiar with. Naproxen, which is sold over the counter as Aleve, is used to manage mild to moderate pain, fever, and inflammation. It works by reducing the production of pain chemicals in the brain. Naproxen was approved by the FDA in December, 1991.
To Buy Pain Meds Online, a Dangerous Move
Many people want to buy pain meds online simply because it is cheaper for them. Recently, thousands of online pharmacies have popped up offering for people to buy pain meds online without a prescription. They offer to sell the medication at cost, or at wholesale prices. This sounds all and good at first, but is it really safe to buy pain meds online?
Chronic Headaches and Pain Often Can Be Eliminated By A Special Dentist
DENVER ? Sometimes as Freud once said a good cigar is just a smoke. A headache, on the other hand, occasionally can be a sign of something much more serious than just a headache.
What You Should Know About Mixing Medications and Diet...
I had a call the other day from a potential client in a serious situation. He was young and had been diagnosed with CAD (Coronary Artery Disease), suffering from extremely high blood pressure and cholesterol, his doctor had put him on a medication that was suppose to lower and control these symptoms, and he had been on this medication for over 2 years.
Dangerous Drugs
Vioxx, Celebrex, and Bextra: An editorial regarding dangerous drugs
Acid Reflux and Your Diet
There is an undeniable connection between the occurrence of acid reflux and diet. Everything in your body has a delicate balance. The human body is a miracle of systems that maintains just the right conditions to keep everything running smoothly. Therefore it's the healthiest when there is an acidic balance or equilibrium. The stomach regulates acidic digestion with enzymes that convert acids into manageable alkaline or basal substances. However, when there is an over-production of acid, usually helped along by lifestyle choices like overeating or smoking, acid reflux is likely to occur, and if it goes unregulated, acid reflux disease can develop.
Health Needs of Survivors of Domestic Violence
Domestic violence is not over when the victim is safe and out of harm's way. It's not
over until justice has been served. Even then, it's not over. It's not over until the
victim is safe, justice has been served, and the victim is well.
Arthritis Pain Relief : Questions To Ask Your Healthcare Provider
A great place to begin taking charge of you arthritis pain relief and prevention planning is by making an appointment with your healthcare provider and finding out more about your condition and treatment options.
Finally...Affordable Prescription Medication without Insurance.
If you are like many Americans, you are without health insurance. And the ranks of the uninsured are growing. According to the National Coalition on Health Care (NCHC), the number of uninsured was a record breaking 45 million in 2003. The growing number of uninsured is in large part being driven by individuals abandoning the corporate life to pursue their dreams as entrepreneurs and small business owners.
Give Me Accutane or Give Me Death: The Politics of Prescriptions
Any teenager will tell you that acne can drive you crazy, but is it dismal enough to drive you to kill yourself? Since its market debut in 1982, enraged parents and lawyers have implicated Accutane in the hospitalizations and suicide deaths of over 200 teenagers in the US.
Medical Malpractice Suits: Death By Medicine
A recent report has found that Americans are more frightened of dying at the hands of their doctor than they are of a plane crash. The overwhelming majority of those who participated in the survey said that information about malpractice suits and medical errors would be the single most deciding factor in trusting a healthcare provider. These people must have heard that medical errors cause more deaths in the United States every year than car accidents, AIDS, or breast cancer.
|
